| Diversity-oriented synthesis of macrocyclic peptidomimetics A Isidro-Llobet, T Murillo, P Bello, A Cilibrizzi, JT Hodgkinson, ... Proceedings of the National Academy of Sciences 108 (17), 6793-6798, 2011 | 131 | 2011 |
| Hydroxypyridinone journey into metal chelation A Cilibrizzi, V Abbate, YL Chen, Y Ma, T Zhou, RC Hider Chemical reviews 118 (16), 7657-7701, 2018 | 75 | 2018 |
| 6-Methyl-2,4-Disubstituted Pyridazin-3(2H)-ones: A Novel Class of Small-Molecule Agonists for Formyl Peptide Receptors A Cilibrizzi, MT Quinn, LN Kirpotina, IA Schepetkin, J Holderness, RD Ye, ... Journal of medicinal chemistry 52 (16), 5044-5057, 2009 | 62 | 2009 |
| An overview of PDE4 inhibitors in clinical trials: 2010 to early 2022 L Crocetti, G Floresta, A Cilibrizzi, MP Giovannoni Molecules 27 (15), 4964, 2022 | 61 | 2022 |
| Optimization of N-Benzoylindazole Derivatives as Inhibitors of Human Neutrophil Elastase L Crocetti, IA Schepetkin, A Cilibrizzi, A Graziano, C Vergelli, D Giomi, ... Journal of medicinal chemistry 56 (15), 6259-6272, 2013 | 61 | 2013 |
| Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition IA Schepetkin, AI Khlebnikov, MP Giovannoni, LN Kirpotina, A Cilibrizzi, ... Current medicinal chemistry 21 (13), 1478-1504, 2014 | 59 | 2014 |
| Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain C Biancalani, MP Giovannoni, S Pieretti, N Cesari, A Graziano, C Vergelli, ... Journal of medicinal chemistry 52 (23), 7397-7409, 2009 | 51 | 2009 |
| Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase L Crocetti, MP Giovannoni, IA Schepetkin, MT Quinn, AI Khlebnikov, ... Bioorganic & medicinal chemistry 19 (15), 4460-4472, 2011 | 46 | 2011 |
| Cinnoline derivatives as human neutrophil elastase inhibitors MP Giovannoni, IA Schepetkin, L Crocetti, G Ciciani, A Cilibrizzi, ... Journal of enzyme inhibition and medicinal chemistry 31 (4), 628-639, 2016 | 44 | 2016 |
| Further studies on 2-arylacetamide pyridazin-3 (2H)-ones: Design, synthesis and evaluation of 4, 6-disubstituted analogs as formyl peptide receptors (FPRs) agonists MP Giovannoni, IA Schepetkin, A Cilibrizzi, L Crocetti, AI Khlebnikov, ... European journal of medicinal chemistry 64, 512-528, 2013 | 40 | 2013 |
| 3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation G Floresta, A Cilibrizzi, V Abbate, A Spampinato, C Zagni, A Rescifina Bioorganic Chemistry 84, 276-284, 2019 | 33 | 2019 |
| Analytical characterization of three cathinone derivatives, 4‐MPD, 4F–PHP and bk‐EPDP, purchased as bulk powder from online vendors O Apirakkan, A Frinculescu, T Shine, MC Parkin, A Cilibrizzi, N Frascione, ... Drug Testing and Analysis 10 (2), 372-378, 2018 | 32 | 2018 |
| Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists A Cilibrizzi, IA Schepetkin, G Bartolucci, L Crocetti, V Dal Piaz, ... Bioorganic & medicinal chemistry 20 (12), 3781-3792, 2012 | 29 | 2012 |
| Functionalized pyrazoles and pyrazolo [3, 4-d] pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity P Biagini, C Biancalani, A Graziano, N Cesari, MP Giovannoni, A Cilibrizzi, ... Bioorganic & Medicinal Chemistry 18 (10), 3506-3517, 2010 | 27 | 2010 |
| 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists C Vergelli, IA Schepetkin, G Ciciani, A Cilibrizzi, L Crocetti, ... Bioorganic & medicinal chemistry 24 (11), 2530-2543, 2016 | 26 | 2016 |
| Synthesis and pharmacological evaluation of new pyridazin‐based thioderivatives as formyl peptide receptor (FPR) agonists L Crocetti, C Vergelli, A Cilibrizzi, A Graziano, AI Khlebnikov, LN Kirpotina, ... Drug Development Research 74 (4), 259-271, 2013 | 24 | 2013 |
| A case of extensive protein platination: The reaction of lysozyme with a Pt (II)–terpyridine complex G Ferraro, T Marzo, T Infrasca, A Cilibrizzi, R Vilar, L Messori, A Merlino Dalton Transactions 47 (26), 8716-8723, 2018 | 23 | 2018 |
| Further studies on pyrazolo [1′, 5′: 1, 6] pyrimido [4, 5-d] pyridazin-4 (3H)-ones as potent and selective human A1 adenosine receptor antagonists MP Giovannoni, G Ciciani, A Cilibrizzi, L Crocetti, S Daniele, ... European Journal of Medicinal Chemistry 89, 32-41, 2015 | 22 | 2015 |
| FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets G Floresta, A Cilibrizzi, V Abbate, A Spampinato, C Zagni, A Rescifina Data in brief 22, 471-483, 2019 | 21 | 2019 |
| The role of mitochondrial labile iron in Friedreich's ataxia skin fibroblasts sensitivity to ultraviolet A O Reelfs, V Abbate, A Cilibrizzi, MA Pook, RC Hider, C Pourzand Metallomics 11 (3), 656-665, 2019 | 20 | 2019 |
